-
Product Insights
NewElectrophysiology Ablation Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Electrophysiology Ablation Catheters Pipeline Market Report Overview Electrophysiology ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence. The electrophysiology ablation catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and...
-
Sector Analysis
NewInternet from Sky – Can LEO Satellites Transform the Future of Connectivity? (Vol. 2)
LEO Satellites - Internet from Sky Report Overview The surge in low earth orbit (LEO) satellite projects indicates a global trend toward diversifying internet coverage. This trend focuses on bridging the digital divide and enhancing real-time data transmission for various sectors, including aerospace and defense. LEOs provide a competitive edge due to their lower latency, and their increasing deployment signifies a pivotal shift toward a more connected future. LEOs are more secure than terrestrial networks as communication happens in space...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anamorelin Hydrochloride in Fatigue
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anamorelin Hydrochloride in Fatigue report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anamorelin Hydrochloride in Fatigue Drug Details: Anamorelin hydrochloride (Adlumiz) is a...
-
Company Insights
Innovation and Patenting activity of Voyager Therapeutics Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Voyager Therapeutics Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Voyager-V1 in Pheochromocytoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Voyager-V1 in Pheochromocytoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Voyager-V1 in Pheochromocytoma Drug Details: Voyager-V1 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Voyager-V1 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Voyager-V1 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Voyager-V1 in Solid Tumor Drug Details: Voyager-V1 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Voyager-V1 in Neuroendocrine Tumors
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Voyager-V1 in Neuroendocrine Tumors report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Voyager-V1 in Neuroendocrine Tumors Drug Details: Voyager-V1 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Voyager-V1 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Voyager-V1 in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Voyager-V1 in Metastatic Colorectal Cancer Drug Details: Voyager-V1 is under development...